Home » News & Events » Presentations » Tim Kosty Presented on Drug Utilization Edits at ASAP Midyear

Tim Kosty Presented on Drug Utilization Edits at ASAP Midyear

PHSI President Tim Kosty presented on “Drug Utilization Edits: Failures, Needs, and Future Direction” at the American Society for Automation in Pharmacy (ASAP) 2017 Midyear Conference. Tim’s presentation reviewed a variety of issues, including historical implementation of DUR edits, pharmacy workflow considerations, choices made by pharmacy chain management to display/suppress messages, payers’ choices on DUR messaging in their claims processing systems, legal implications, and future strategies and tactics. Click here to view Tim’s presentation slides.

February 2023 Question of the Month

Do you feel like your organization understands the FDA’s Draft Guidance for Industry on Drug Importation?

We have reviewed the guidance and are taking a watch and wait approach: 75%

We have reviewed the guidance and are taking proactive steps to act on it: 25%

We have reviewed the guidance but do not feel like it will impact our organization: 0%

Not familiar/We have not reviewed the guidance: 0%

January 2023 Question of the Month

How will payers manage reimbursement of multiple interchangeable biosimilars?

MAC reimbursement: 10%

Generic non-MAC reimbursement rate: 10%

Brand reimbursement rate: 40%

Specialty drug specific rate: 40%

Average Sales Price (ASP): 0%

Average Manufacturer Price (AMP): 0%

National Average Drug Acquisition Cost (NADAC): 0%

December 2022 Question of the Month

In which area could you or your company most benefit from additional training?

Biosimilars and interchangeability requirements: 46.1%

Dynamics that drive PBM and health plan decisions: 15.4%

Various hurdles a prescription must clear before being dispensed: 15.4%

Changing 340B landscape: 15.4%

Flow of funds and prescriptions through the pharmacy channels: 7.7%

Pharmacy chain initiatives and strategy updates: 0%